MRNA: Moderna, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 14,719.28
Enterprise Value ($M) 13,075.28
Book Value ($M) 11,927.00
Book Value / Share 30.99
Price / Book 1.23
NCAV ($M) 5,790.00
NCAV / Share 15.05
Price / NCAV 2.54

Profitability (mra)
Return on Invested Capital (ROIC) -0.17
Return on Assets (ROA) -0.11
Return on Equity (ROE) -0.17

Liquidity (mrq)
Quick Ratio 4.20
Current Ratio 4.39

Balance Sheet (mrq) ($M)
Current Assets 9,666.00
Assets 15,803.00
Liabilities 3,876.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-10 13G/A Vanguard Group Inc 10.20 15.13
02-07 13G/A Bancel Stephane 7.80 4.23
01-29 13G/A BlackRock, Inc. 6.60 -3.12
01-29 13G/A Baillie Gifford & Co 11.97 1.94

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-02-23 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-22 2,956,101 12,593,733 23.47
2024-11-21 1,980,481 8,109,935 24.42
2024-11-20 1,727,416 6,475,638 26.68
2024-11-19 2,090,816 8,013,962 26.09
2024-11-18 2,633,104 12,225,273 21.54

(click for more detail)

Similar Companies
MIST – Milestone Pharmaceuticals Inc. MLYS – Mineralys Therapeutics, Inc.
MNMD – Mind Medicine (MindMed) Inc. MRSN – Mersana Therapeutics, Inc.
MRVI – Maravai LifeSciences Holdings, Inc.


Financial data and stock pages provided by
Fintel.io